EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Acellular pertussis vaccines in diverse populations: a review of effectiveness, immunogenicity, and safety

Yupeng Wang, Shuangxing Li, Kunqi Zou, Boyuan Xuan, Mengchao Zhao, Liyong Yuan, Xingchao Geng

Frontiers in Microbiology · 30.10.2026 · 17

DOI: 10.3389/fmicb.2026.1981584 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.10.2026. Verfasst von Yupeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biological Product Control, National Institutes for Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biot…. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pertussis remains an important vaccine-preventable respiratory disease, particularly in young infants. Because of their lower reactogenicity, acellular pertussis vaccines have replaced whole-cell vaccines in many countries and are widely used for infant primary immunization, booster vaccination in children, adolescents and adults, and maternal immunization. However, pertussis resurgence, waning immunity, antigen-deficient circulating strains and limited effects on nasopharyngeal colonization have renewed interest in antigen composition, immune mechanisms and clinical protection. This narrative review synthesizes evidence on acellular pertussis vaccines across different populations, focusing on: clinical protection and waning after infant and childhood vaccination; immunogenicity and safety of adolescent and adult boosters; maternal vaccination and its effects on early infant protection and subsequent immune responses; and product-specific evidence on combination vaccination and coadministration. Rather than attempting an exhaustive comparison of all products and studies, this review highlights representative clinical evidence and distinguish clinical outcomes from immunogenicity and safety endpoints. Current data indicate that pertussis toxin-containing acellular vaccines induce clear antibody responses, and multicomponent formulations broaden antigenic coverage. Three-component or higher acellular vaccines have shown efficacy of approximately 84–85% against typical childhood pertussis, but protection after DTaP wanes over time. DTaP and Tdap are generally well tolerated; most adverse events are mild-to-moderate local or transient systemic reactions. Maternal Tdap improves early infant antibodies but may blunt some subsequent infant responses. Future research should define correlates of protection, evaluate antigen variation, and strengthen evidence on mucosal immunity, coadministration, real-world effectiveness and long-term safety.

Schlagwörter

Stichwörter der Autor:innen

DTaPTdapacellular pertussis vaccinebluntingimmunogenicitymaternal immunizationsafetyvaccine effectiveness

Autor:innen und Institutionen

  • Institute for Biological Product Control, National Institutes for Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products and NMPA Key Laboratory for Quality Research and Evaluati…
  • National Center for Safety Evaluation of Drugs, National Institutes for Drug Control, Beijing, China.
  • Department of Pharmacy, General Hospital of Ningxia Medical University, Ningxia, China.

Zitieren

APA

Wang, Y., Li, S., Zou, K., Xuan, B., Zhao, M., Yuan, L., & Geng, X. (2026). Acellular pertussis vaccines in diverse populations: a review of effectiveness, immunogenicity, and safety. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1981584

Vancouver

Wang Y, Li S, Zou K, Xuan B, Zhao M, Yuan L, et al. Acellular pertussis vaccines in diverse populations: a review of effectiveness, immunogenicity, and safety. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1981584

BibTeX
@article{Wang2026,
  author = {Wang, Yupeng and Li, Shuangxing and Zou, Kunqi and Xuan, Boyuan and Zhao, Mengchao and Yuan, Liyong and Geng, Xingchao},
  title = {Acellular pertussis vaccines in diverse populations: a review of effectiveness, immunogenicity, and safety},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1981584}
}
Kostenlos starten →